$0.487
-0.068 (-13.96%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NMRA por análisis de gráficos similares
Alphio's NMRA stock price prediction model matches the current Neumora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.48 (-1.73%). The 1-week path is $0.48 (-0.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Neumora Therapeutics Inc?
Neumora Therapeutics Inc is a good buy right now due to its recent price increase of 34.99% yesterday and a 5-day change of 26.16%, indicating strong momentum. The RSI is at 68.963, suggesting it is nearing overbought territory but still has room to grow. However, the company has a significant risk with a net loss of $43.1 million reported for Q2 2026, which highlights ongoing financial challenges. Overall, the potential for recovery and upside in the stock price makes it an attractive buy despite the risks.
NMRA cerró en $0.49 el Thursday, tras bajar -13.96%
Neumora Therapeutics Inc (NMRA) last closed at $0.487, losing -13.96%. These facts feed the 1-day and 1-week NMRA price prediction above.
Factores de la previsión
Los factores de la previsión de Neumora Therapeutics Inc (NMRA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NMRA, ordenadas por similitud.
Análisis de estacionalidad de NMRA
Historically the probability of a positive November return for NMRA is 43.18%. February offers the highest probability of a positive month at 60.34%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NMRA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $2.23 | $2.23 | $2.41 | +358.70% |
| Dec 2026 | $1.48 | $1.81 | $1.86 | +271.51% |
En 2026, se proyecta que Neumora Therapeutics Inc (NMRA) oscile entre $1.48 y $2.41.
Previsión mensual de Neumora Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Neumora Therapeutics Inc promedie $2.23, con un mínimo de $2.23 y un máximo de $2.41.
En Dec de 2026, se proyecta que Neumora Therapeutics Inc promedie $1.81, con un mínimo de $1.48 y un máximo de $1.86.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.